Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last hours
Enjoy this offer
* See conditions on site

Valuation: Becton, Dickinson and Company

Capitalization 64.16B 60.81B 56.57B 50.5B 89.88B 5,426B 98.51B 700B 261B 2,226B 241B 236B 9,656B P/E ratio 2025 *
27.9x
P/E ratio 2026 * 29.1x
Enterprise value 81.25B 77.01B 71.64B 63.95B 114B 6,872B 125B 887B 330B 2,819B 305B 298B 12,228B EV / Sales 2025 *
3.7x
EV / Sales 2026 * 3.3x
Free-Float
77.79%
Yield 2025 *
1.75%
Yield 2026 * 1.83%
More valuation ratios * Estimated data
Dynamic Chart
1 day-0.04%
1 week-0.94%
1 month-5.00%
3 months-8.46%
6 months-4.34%
Current year-8.99%
More quotes
1 week
220.29
Extreme 220.29
226.67
1 month
220.29
Extreme 220.29
244.33
Current year
218.75
Extreme 218.75
249.89
1 year
218.75
Extreme 218.75
249.89
3 years
215.90
Extreme 215.9
287.32
5 years
197.75
Extreme 197.75
287.32
10 years
128.87
Extreme 128.87
287.32
More quotes
Director TitleAgeSince
Chief Executive Officer 50 27/01/2020
Director of Finance/CFO 52 05/09/2021
Chief Tech/Sci/R&D Officer 54 03/12/2023
Manager TitleAgeSince
Director/Board Member 73 23/09/2002
Director/Board Member 68 19/11/2006
Director/Board Member 69 25/07/2010
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-0.04%-0.94%-6.05%-6.43%64.16B
-0.15%+0.86%+13.88%-5.57%206B
+0.31%+0.38%+9.17%-18.89%111B
+0.74%+2.67%+23.69%+117.32%48.62B
-1.21%-0.59%+15.57%+6.88%44.52B
-0.14%+7.08%-32.49%-44.55%30.46B
-0.94%-0.72%+29.33%+31.85%30.01B
+0.73%+2.87%-7.15%-26.43%23.59B
+0.07%+1.71%-3.62%-6.27%22.31B
+0.73%+2.20%+9.02%+0.24%21.62B
Average +0.01%+2.03%+5.14%+4.82% 60.23B
Weighted average by Cap. -0.02%+2.05%+8.59%+1.99%
See all sector performances

Financials

2025 *2026 *
Net sales 21.97B 20.82B 19.37B 17.29B 30.78B 1,858B 33.73B 240B 89.31B 762B 82.53B 80.69B 3,306B 23.01B 21.81B 20.29B 18.12B 32.24B 1,946B 35.34B 251B 93.56B 798B 86.46B 84.54B 3,464B
Net income 2.35B 2.23B 2.08B 1.85B 3.3B 199B 3.61B 25.7B 9.57B 81.66B 8.84B 8.65B 354B 2.57B 2.44B 2.27B 2.02B 3.6B 217B 3.95B 28.06B 10.45B 89.17B 9.66B 9.44B 387B
Net Debt 17.09B 16.2B 15.07B 13.45B 23.94B 1,445B 26.24B 187B 69.48B 593B 64.21B 62.78B 2,572B 11.77B 11.15B 10.38B 9.26B 16.49B 995B 18.07B 128B 47.84B 408B 44.21B 43.23B 1,771B
More financial data * Estimated data
Logo Becton, Dickinson and Company
Becton, Dickinson and Company specializes in the development, manufacturing and marketing of medical and diagnostic equipment and materials. Net sales break down by family of products as follows: - medical equipment (73.5%): surgical instruments, urological care products, pharmaceutical systems, etc.; - diagnostic materials (18.7%): automated systems for blood testing, mycobacteria detection, and molecular biology, medical biology devices, etc.; - clinical research and development tools (7.8%): tools for discovering drugs and vaccines, studying genes, culturing cells, and manipulating liquids, instruments for sorting and analyzing cells, monoclonal antibodies, etc. Net sales are distributed geographically as follows: the United States (57.4%), Europe/Middle East/Africa (21.9%), Asia (15%) and other (5.7%).
Employees
74,000
More about the company
Date Price Change Volume
29/11/24 221.90 $ -0.04% 1,210,254
27/11/24 221.98 $ -1.01% 2,373,230
26/11/24 224.25 $ -0.55% 2,176,561
25/11/24 225.48 $ +0.66% 1,914,590
22/11/24 224.00 $ -0.64% 1,677,611

Delayed Quote Nyse, November 29, 2024 at 06:00 pm

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
A
surperformance-ratings-light-chart BECTON-DICKINSON-AND-COMPMore Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
18
Last Close Price
221.90USD
Average target price
281.10USD
Spread / Average Target
+26.68%
Consensus

Quarterly revenue - Rate of surprise

LAST HOURS | BLACK FRIDAY -40%: Unlock Tomorrow's Top Investments with Our Exclusive Subscriber-Only Tools!
d
:
:
BENEFIT NOW